Andreea Bodnari is an AI technology entrepreneur and executive. She is the founder and CEO of ALIGNMT AI, a pioneering Healthcare AI risk monitoring and compliance startup that enables healthcare companies to evolve with trustworthy AI that meets US and EU regulatory standards.

Before her current role, Andreea was a product executive leading Healthcare AI at UnitedHealth Group and Google Cloud, where she spearheaded AI products and evaluation platforms focused on healthcare workforce augmentation. Andreea previously launched and exited several technology startups driving workforce optimization through AI in healthcare and financial services. She sits on the Executive Advisory Board for Data Science and AI at WPI.

Andreea was awarded a Chateaubriand fellowship to strengthen collaborations in healthcare AI between French and American research teams and she graduated with a Ph.D. in Machine Learning from MIT and a B.S. from WPI.

Melissa Bowley is the Founder and CEO of Flourish Care, a tech-enabled healthcare company reshaping how maternal care is delivered by integrating reimbursed doula support into clinical systems. With a background in biomedical engineering and a career leading product development and commercial strategy in medical device and digital health, she has launched over 10 products and driven $200M+ in revenue‚ building teams, scaling operations, and forging lasting partnerships with payers and providers.

Flourish grew out of Melissa’s firsthand experience with a fragmented system during her own pregnancies, where vital support was missing in the moments it was needed most. Melissa leads with a patient-first, family-centered mindset‚ designing systems that integrate with clinical workflows while meeting families where they are. She is a national voice in the maternal health movement, collaborating with policymakers and payers to scale sustainable reimbursement models that bring this care to more families.

A mom of two and advocate for women-led innovation, Melissa also leads New England Female Founders, a nonprofit supporting the next generation of female entrepreneurs. Her mission is simple: ensure that every family has the support they need before, during, and after birth.

Shital Daftari is the Founder and CEO of SNT Biotech, a high-growth healthcare company redefining how health plans address gaps in care through scalable at-home diagnostic screening solutions. Known for her strategic leadership and operational execution, Shital built SNT Biotech to deliver measurable value to health plans by improving quality scores, increasing member engagement, and reducing costs through early detection.

In 2021, she launched a CLIA- and COLA-accredited laboratory and built a fully integrated platform that supports end-to-end program delivery—including custom test kit creation, multilingual outreach, lab processing, and real-time analytics. Today, SNT Biotech enables health plans to screen for chronic and preventive conditions such as colorectal cancer, diabetes, kidney disease, and cervical cancer with precision, speed, and cultural sensitivity.

Shital is a graduate of the Harvard Business School Owner/President Management (OPM) program and is an active member of YPO and the Women Presidents Organization. Her business acumen has earned national recognition: Inc. 5000, Crain’s Chicago Fast 50, and inclusion for three consecutive years among the Top 50 Fastest Growing Women-Owned/Led Companies in America by the Women Presidents Organization and JP Morgan Chase.

Meghan Doyle is the CEO and Co-Founder of Partum Health, where she combines her experience in healthcare and strategy with her passion for supporting women and families.

Meghan started Partum after cobbling together (and doing without) essential care before and after the birth of her two children. She experienced these gaps firsthand while working as a health care consultant with Boston Consulting Group. In that role, she supported leading payer, provider, and health services clients with growth and strategy efforts, which helped to illuminate the gap between the exciting innovation happening in other areas vs. the lag in women’s health. At BCG, Meghan’s work included classic strategy work, value-based care program design, patient insights and experience work, and mergers and integration.

Meghan also served as an early team member at pediatric Cognitive Behavioral Therapy startup Doctor Lullaby and started her career with a focus on consumer marketing. She has deep respect for patients as consumers and brings the lens of consumer insights and needs to her work at Partum Health every day.

Meghan has an MBA from The Wharton School at the University of Pennsylvania and a BA from UNC-Chapel Hill. She is proud to be building Partum Health in her home city of Chicago, where she lives with her husband and two kids.

Lauren Gage is the Founder and CEO of Triplemoon and also a DONA International trained Birth Doula and Post-Partum Doula. In addition to her “day job” Lauren is a proud mom to her daughter, Vivienne, who was born in 2022. Her family’s lived experience with the joys and difficulties of parenthood was the inspiration behind Triplemoon.

Prior to starting Triplemoon, Lauren worked for 15+ years in professional services between McKinsey & Company, where she specialized in growth transformations, and Goldman Sachs, where she held roles across several divisions of the bank, including operations and alternative investments. She has her M.B.A. from Duke University and her B.B.A. from the University of Michigan.

Lyndsey Garbi, MD, is double board-certified in neonatology and pediatrics and serves as the Chief Medical Officer and cofounder at Blueberry Pediatrics, a leading pediatric telehealth company dedicated to providing high-quality, accessible care for children nationwide. A passionate advocate for equitable, evidence-based medicine, Dr. Garbi helped found Blueberry Pediatrics to reimagine how families access pediatric care—making it easier, more affordable, and always available.

In addition to her role at Blueberry, Dr. Garbi is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. She is also an active member of the American Academy of Pediatrics and brings a clinician’s insight and a parent’s empathy to her work, drawing on her experience as a mother of three.

Dr. Garbi earned her undergraduate degree from Emory University and completed medical school at the Sackler School of Medicine, New York State/American Program of Tel Aviv University. She went on to complete her pediatric residency at Cohen Children’s Hospital and her neonatology fellowship at Maria Fareri Children’s Hospital at Westchester Medical Center. In 2016, she also earned a certificate in pediatric bioethics from the Children’s Mercy Center for Bioethics, where she trained under nationally recognized leaders in ethics and pediatric care.

Rachael Jones is the CEO and Co-Founder of Syntax Health, a company transforming value-based care through transparent collaboration and actuarial intelligence. With over 25 years in healthcare, Rachael has led teams at national health plans and vendors—including Anthem, Healthfirst, Trizetto, and Cotiviti—driving network strategy, quality, and risk adjustment operations. Her work over the past 15 years has centered on making value-based care work for both providers and payers.

As a first-generation Jamaican founder, Rachael brings a deep personal commitment to equity and sustainability in healthcare. She founded Syntax to bridge the operational and analytical gaps that make VBC inaccessible for too many providers—particularly community health centers and mission-driven organizations. In just over a year since launching its platform, Syntax has already helped provider organizations secure millions in potential incentive revenue through smarter contracting and performance monitoring.

Rachael was recently recognized by Rock Health as one of the Top 50 in Digital Health in the “System Disruptors” category. She is passionate about helping others navigate the founder journey and regularly speaks on topics including women’s leadership, equity in innovation, and the future of value-based care.

Amy Lorincz is the CEO and Co-Founder of vopemed, launched in 2021 to develop AI-driven software that enhances vision in minimally invasive surgeries. With a background in Industrial Engineering and a Master’s in Experimental Surgery, Amy is passionate about optimizing healthcare systems to improve surgical outcomes. She secured pre-seed funding to bring her vision of empowering surgeons for safer, more efficient surgeries to life.

Her career includes R&D on surgical robotics and leading 50+ clinical validation projects for medical software, where she combines her drive for innovation with a commitment to advancing healthcare.

Elizabeth K. Ruzzo, PhD, completed her graduate work at Duke University and her postdoc at UCLA. She has authored 35+ peer-reviewed publications, garnering over 5,300 citations (including publications in Nature and Cell). Throughout her 10+ year academic career in human genomics and medical genetics, she discovered nearly 40 genetic causes for various human diseases. She has dedicated her expertise in precision medicine to closing gaps caused by historic inequity in medical research and demanding a new standard of care.

She founded adyn with the mission of making scientific discovery more inclusive. Dr. Ruzzo took adyn through Y Combinator and has received the Charles J. Epstein Trainee Awardee for Excellence in Human Genetics Research, the Jo Rae Wright Fellowship for Outstanding Women in Science, the Neurobehavioral Genetics Fellowship, and the Ray J. Tysor Graduate Fellowship. Her work has also been recognized by CB Insights, Fast Company, Inc. Magazine, and Rock Health.

Cathy Skinner is a former collegiate volleyball coach turned serial entrepreneur. Cathy has 20+ years of successful healthcare experience building businesses, differentiated products, and services that manage healthcare costs and improve patient outcomes.

Cathy’s passion originated with her father’s cancer diagnosis and led her to launch three different oncology startups providing products and services for cancer patients and their loved ones. She is driven to move companies from ideation to commercialization by bringing together top talent and subject matter experts to build differentiated patient experiences.

Previously, Cathy coached 400+ cancer patients, empowering them through physical activity and nutrition. Now, Cathy is the CEO of NXgenPort.com, which harnesses the power of machine learning and remote patient monitoring with an implanted Smart Port that detects infection.